Dickinson Andrew D's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Feb 13, 2025
- Accession no.
- 0001127602-25-004784
- Filed
- Feb 13, 2025
- Trade date
- Feb 12, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $14.1M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dickinson Andrew DCIK 0001310204 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | MOption exerciseAcquired | +77,691 | $63.91 | +$4,965,231.81 | 248,914 | Direct | |
| Feb 12, 2025 | Common Stock | MOption exerciseAcquired | +26,175 | $57.92 | +$1,516,056 | 275,089 | Direct | |
| Feb 12, 2025 | Common Stock | MOption exerciseAcquired | +15,600 | $80.72 | +$1,259,232 | 290,689 | Direct | |
| Feb 12, 2025 | Common Stock | MOption exerciseAcquired | +18,210 | $83.49 | +$1,520,352.9 | 308,899 | Direct | |
| Feb 12, 2025 | Common Stock | SSaleDisposed | −137,676 | $102.22 | −$14,073,240.72 | 171,223 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | MOption exerciseDisposed | −77,691 | $0.00 | $0 | 17,929 | Direct | |
| Feb 12, 2025 | Common Stock | MOption exerciseDisposed | −26,175 | $0.00 | $0 | 78,515 | Direct | |
| Feb 12, 2025 | Common Stock | MOption exerciseDisposed | −15,600 | $0.00 | $0 | 0 | Direct | |
| Feb 12, 2025 | Common Stock | MOption exerciseDisposed | −18,210 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.